Mycoplasma pneumoniae infection induces a neutrophil-derived antimicrobial peptide, cathelin-related antimicrobial peptide

Microbiology and Immunology

Volumn 55, Issue 8, 2011, Pages 582-588

  Tani, Kenji ^a   Shimizu, Takashi ^a   Kida, Yutaka ^a   Kuwano, Koichi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antimicrobial peptide; Cathelin related antimicrobial peptide; Mycoplasma pneumoniae; Neutrophil

Indexed keywords

CATHELIN RELATED ANTIMICROBIAL PEPTIDE; POLYPEPTIDE ANTIBIOTIC AGENT; THIOGLYCOLIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL IMMUNITY; BACTERIAL STRAIN; CELL FUNCTION; CELL SECRETION; CELL STIMULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; GROWTH INHIBITION; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; LUNG LAVAGE; MOUSE; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; NEUTROPHIL; NONHUMAN; PROTEIN INDUCTION; QUANTITATIVE ANALYSIS; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BRONCHOALVEOLAR LAVAGE FLUID; CATHELICIDINS; CYTOPLASM; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; MICE; MICE, INBRED BALB C; MICROSCOPY, FLUORESCENCE; MYCOPLASMA PNEUMONIAE; NEUTROPHILS; PNEUMONIA, MYCOPLASMA; RODENT DISEASES;

MUS; MYCOPLASMA PNEUMONIAE; MYCOPLASMATALES; POSIBACTERIA;

EID: 79960860859     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2011.00353.x     Document Type: Article

References (28)

1. Kennedy A.D., DeLeo F.R. (2009) Neutrophil apoptosis and the resolution of infection. Immunol Res 43: 25-61.
2. Ermert D., Urban C.F., Laube B., Goosmann C., Zychlinsky A., Brinkmann V. (2009) Mouse neutrophil extracellular traps in microbial infections. J Innate Immun 1: 181-93.
3. Bals R. (2000) Epithelial antimicrobial peptides in host defense against infection. Respir Res 1: 141-50.
4. Hancock R.E., Scott M.G. (2000) The role of antimicrobial peptides in animal defenses. Proc Natl Acad Sci U S A 97: 8856-61.
5. Bals R., Wang X., Zasloff M., Wilson J.M. (1998) The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc Natl Acad Sci U S A 95: 9541-46.
6. Gallo R.L., Kim K.J., Bernfield M., Kozak C. A., Zanetti M., Merluzzi L., Gennaro R. (1997) Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse. J Biol Chem 272: 13088-93.
7. Nizet V., Ohtake T., Lauth X., Trowbridge J., Rudisill J., Dorschner R.A., Pestonjamasp V., Piraino J., Huttner K., Gallo R.L. (2001) Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414: 454-57.
8. Howell M.D., Jones J.F., Kisich K.O., Streib J.E., Gallo R.L., Leung D.Y. (2004) Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum. J Immunol 172: 1763-67.
9. Krause D., Taylor-Robinson D. (1992) Mycoplasmas which infect humans. In: Maniloff J., McElhaney R.N., Finch L.R., Baseman J.B., eds. Mycoplasmas Molecular Biology and Pathogenesis. Washington, D.C American Society for Microbiology, pp. 417-44.
10. Waites K.B., Talkington D.F. (2004) Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev 17: 697-728.
11. Martin R.J., Chu H.W., Honour J.M., Harbeck R.J. (2001) Airway inflammation and bronchial hyper-responsiveness after Mycoplasma pneumoniae infection in a murine model. Am J Respir Cell Mol Biol 24: 577-82.
12. Simecka J.W. (2005) Immune responses following mycoplasma infection. In: Blanchard A., Browning G. eds. Mycoplasmas. Norfolk, UK Horizon Bioscience, pp. 485-534.
13. Kuwano K., Tanaka N., Shimizu T., Kida Y. (2006) Antimicrobial activity of inducible human beta defensin-2 against Mycoplasma pneumoniae. Curr Microbiol 52: 435-38.
14. Arai S., Furukawa M., Munakata T., Kuwano K., Inoue H., Miyazaki T. (1990) Enhancement of cytotoxicity of active macrophages by mycoplasma: role of mycoplasma-associated induction of tumor necrosis factor-alpha (TNF-alpha) in macrophages. Microbiol Immunol 34: 231-43.
15. Shimizu T., Kida Y., Kuwano K. (2008) Mycoplasma pneumoniae-derived lipopeptides induce acute inflammatory responses in the lungs of mice. Infect Immun 76: 270-77.
16. Hornbeck P. (1994) Enzyme-linked immunosorbent assays. In: Coligan J.E. ed. Current Protocols in Immunology. New York Wiley, unit 2.1.
17. Asai T., Okada M., Yokomizo Y., Sato S., Mori Y. (1996) Suppressive effect of bronchoalveolar lavage fluid from pigs infected with Mycoplasma hyopneumoniae on chemiluminescence of porcine peripheral neutrophils. Vet Immunol Immunopathol 51: 325-31.
18. Thomsen A.C., Heron I. (1979) Effect of mycoplasmas on phagocytosis and immunocompetence in rats. Acta Pathol Microbiol Scand C 87: 67-71.
19. Thomas C.B., Van Ess P., Wolfgram L.J., Riebe J., Sharp P., Schultz R.D. (1991) Adherence to bovine neutrophils and suppression of neutrophil chemiluminescence by Mycoplasma bovis. Vet Immunol Immunopathol 27: 365-81.
20. Broaders S.A., Hooper W.C., Phillips D.J., Talkington D.F. (2006) Mycoplasma pneumoniae subtype-independent induction of proinflammatory cytokines in THP-1 cells. Microb Pathog 40: 286-92.
21. Di Nardo A., Vitiello A., Gallo R.L. (2003) Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J Immunol 170: 2274-8.
22. Travis S.M., Anderson N.N., Forsyth W.R., Espiritu C., Conway B.D., Greenberg E.P., McCray P.B., Lehrer R.I. Jr., Welsh M.J., Tack B.F. (2000) Bactericidal activity of mammalian cathelicidin-derived peptides. Infect Immun 68: 2748-55.
23. Chromek M., Slamova Z., Bergman P., Kovacs L., Podracka L., Ehren I., Hokfelt T., Gudmundsson G.H., Gallo R.L., Agerberth B., Brauner A. (2006) The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med 12: 636-41.
24. Mendez-Samperio P., Miranda E., Trejo A. (2008) Expression and secretion of cathelicidin LL-37 in human epithelial cells after infection by Mycobacterium bovis Bacillus Calmette-Guérin. Clin Vaccine Immunol 15: 1450-55.
25. Rana F.R., Blazyk J. (1991) Interactions between the antimicrobial peptide, magainin 2, and Salmonella typhimurium lipopolysaccharides. FEBS Lett 293: 11-15.
26. Scott M.G., Gold M.R., Hancock R.E. (1999) Interaction of cationic peptides with lipoteichoic acid and gram-positive bacteria. Infect Immun 67: 6445-53.
27. Rottem S., Markowitz O. (1979) Unusual positional distribution of fatty acids in phosphatidylglycerol of sterol-requiring mycoplasmas. FEBS Lett 107: 379-82.
28. Salman M., Rottem S. (1995) The cell membrane of Mycoplasma penetrans: lipid composition and phospholipase A1 activity. Biochim Biophys Acta 1235: 369-377.